In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Zafgen, Inc.. Trade Record

NASDAQ:ZFGN Zafgen, Inc. stock gains 46.08% Exit Jan 29, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart ZFGN Dec 20, 2017, priceSeries
About Zafgen, Inc.

Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from metabolic diseases comprising type 2 diabetes and obesity. The company's lead product candidate is ZGN-1061, a fumagillin-class MetAP2 inhibitor administered by subcutaneous injection, which is in Phase 1 clinical trial and profiled for its utility in the treatment of metabolic diseases. Zafgen, Inc. was founded in 2005 and is based in Boston, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
97.96
Entry Date
Dec 20, 2017
Entry Price
3.95
Sell Date
Jan 29, 2018
Sell Price
5.77
Net Gain
46.08%
Hold Time
25 Trading Days